| __timestamp | BioCryst Pharmaceuticals, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7461000 | 17992000000 |
| Thursday, January 1, 2015 | 13047000 | 22400000000 |
| Friday, January 1, 2016 | 11253000 | 23910000000 |
| Sunday, January 1, 2017 | 13933000 | 23813000000 |
| Monday, January 1, 2018 | 29514000 | 24694000000 |
| Tuesday, January 1, 2019 | 37121000 | 23557000000 |
| Wednesday, January 1, 2020 | 67929000 | 25436000000 |
| Friday, January 1, 2021 | 118818000 | 24586000000 |
| Saturday, January 1, 2022 | 159371000 | 27295000000 |
| Sunday, January 1, 2023 | 213894000 | 34205000000 |
| Monday, January 1, 2024 | 28113000000 |
Cracking the code
In the world of corporate finance, Selling, General, and Administrative (SG&A) expenses are a crucial indicator of a company's operational efficiency. This analysis compares the SG&A expenses of Walgreens Boots Alliance, Inc. and BioCryst Pharmaceuticals, Inc. from 2014 to 2023. Walgreens, a retail giant, consistently reported SG&A expenses exceeding $20 billion annually, reflecting its expansive global operations. In contrast, BioCryst, a smaller pharmaceutical firm, saw its SG&A expenses grow from approximately $7 million in 2014 to over $213 million in 2023, marking a staggering increase of nearly 2,800%. This growth highlights BioCryst's aggressive expansion and investment in its operations. Notably, Walgreens' expenses peaked in 2024, while BioCryst's data for that year remains unavailable. This comparison underscores the diverse financial strategies and growth trajectories of these two distinct companies.
Selling, General, and Administrative Costs: Novartis AG vs Walgreens Boots Alliance, Inc.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ascendis Pharma A/S
Walgreens Boots Alliance, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Walgreens Boots Alliance, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Veracyte, Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Perrigo Company plc
Selling, General, and Administrative Costs: Exelixis, Inc. vs BioCryst Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
ImmunityBio, Inc. vs BioCryst Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.